Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients

AB023 reduces dialyzer clotting compared to placebo during heparin-free dialysis, and continues to be safe and well tolerated
PORTLAND, Ore., July 19, 2021 /PRNewswire/ — Aronora Inc., a clinical s… Read full article

Leave a comment

Your email address will not be published. Required fields are marked *